Monte Rosa Therapeutics, Inc. earnings per share and revenue

GLUE earnings per share for the last quarter are -0.29 USD whereas the estimation was -0.47 USD which accounts for 38.89% surprise. Company revenue for the same period amounts to 9.20 M USD despite the estimated figure of 2.64 M USD. Estimated earnings per share for the next quarter are 0.18 USD, and revenue is expected to reach 51.19 M USD. Also watch annual changes over time to get a bigger picture of GLUE earnings per share and revenue dynamics.